PACS CEO sells 19,617 shares in trading plan

PACS Group’s CEO and chairman reported open-market sales of 19,617 common shares under a pre-arranged Rule 10b5-1 trading plan.

Rhea-AI Filing Summary

PACS Group, Inc. (PACS) Co-Founder, CEO & Chairman and ten percent owner Murray Jason Hulse reported selling a total of 19,617 shares of common stock in three open-market transactions on September 10, 11 and 14, 2026, at weighted average prices around $45 per share.

Each transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 18, 2026, with prices disclosed as weighted averages over ranges between $45.00 and approximately $45.76 per share.

Insider Trade Summary 10b5-1

Net Seller: 19,617 shares

Net Sell 3 txns

Insider Murray Jason Hulse

Role Co-Founder, CEO & Chairman

Sold 19,617 shs ($887K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1, F4	317	$45.0309	$14K
Sale	Common Stock F1, F3	10,529	$45.2265	$476K
Sale	Common Stock F1, F2	8,771	$45.1608	$396K

Holdings After Transaction: Common Stock — 54,555,249 shares (Direct)

Footnotes (4)

1. F1. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026.
2. F2. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.4775 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. F3. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.76 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. F4. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.12 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold September 10, 2026: 8,771 shares at $45.1608 per share (weighted average) Shares sold September 11, 2026: 10,529 shares at $45.2265 per share (weighted average) Shares sold September 14, 2026: 317 shares at $45.0309 per share (weighted average) +4 more

7 metrics

Shares sold September 10, 2026 8,771 shares at $45.1608 per share (weighted average) Open-market sale of PACS common stock by CEO Murray Jason Hulse

Shares sold September 11, 2026 10,529 shares at $45.2265 per share (weighted average) Open-market sale of PACS common stock by CEO Murray Jason Hulse

Shares sold September 14, 2026 317 shares at $45.0309 per share (weighted average) Open-market sale of PACS common stock by CEO Murray Jason Hulse

Total shares sold 19,617 shares Sum of the three reported sales of PACS common stock

Price range September 10, 2026 $45.00 to $45.4775 per share Range of individual trade prices underlying the weighted average

Price range September 11, 2026 $45.00 to $45.76 per share Range of individual trade prices underlying the weighted average

Price range September 14, 2026 $45.00 to $45.12 per share Range of individual trade prices underlying the weighted average

Key Terms

Rule 10b5-1 trading plan, weighted average price

2 terms

Rule 10b5-1 trading plan regulatory

"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did PACS Group (PACS) disclose about insider share sales in this Form 4?

The Co-Founder, CEO & Chairman, Murray Jason Hulse, reported selling 19,617 shares of PACS Group common stock in three open-market transactions on September 10, 11 and 14, 2026, at weighted average prices of about $45 per share, under a Rule 10b5-1 trading plan.

At what prices were the PACS (PACS) insider’s shares sold?

Reported prices are weighted averages: $45.1608 on September 10 for 8,771 shares, $45.2265 on September 11 for 10,529 shares, and $45.0309 on September 14 for 317 shares. Actual sale prices occurred in ranges between $45.00 and about $45.76 per share.

How many PACS (PACS) shares did the CEO sell on each date?

Murray Jason Hulse sold 8,771 shares on September 10, 2026, 10,529 shares on September 11, 2026, and 317 shares on September 14, 2026, for a total of 19,617 shares of PACS Group common stock.

Were the recent PACS (PACS) insider sales made under a Rule 10b5-1 trading plan?

Yes. A footnote states that each reported sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2026, and the filing’s Rule 10b5-1 checkbox is marked as affirmed.

Does the PACS (PACS) Form 4 state the exact prices for each individual trade?

No. For each transaction, the reported price is a weighted average price. Footnotes explain that the shares were sold in multiple trades within price ranges (for example, from $45.00 to $45.76) and that full trade-by-trade details are available on request.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/14/2026 - 06:38 PM Accepted by SEC EDGAR 09/14/2026 - 06:38 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Murray Jason Hulse

(Last) (First) (Middle)

C/O PACS GROUP, INC.

90 S. 400 W. SUITE 700

(Street)

SALT LAKE CITY UTAH 84101

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PACS Group, Inc. [ PACS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Co-Founder, CEO & Chairman

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/10/2026		S(1)		8,771	D	$45.1608(2)	54,566,095	D
Common Stock	09/11/2026		S(1)		10,529	D	$45.2265(3)	54,555,566	D
Common Stock	09/14/2026		S(1)		317	D	$45.0309(4)	54,555,249	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026.

2. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.4775 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.76 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.12 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ John Mitchell, Attorney-in-Fact	09/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)